You are here: Industry Insights > Factor H

News List

Eleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H prnasia
September 23, 2021
Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors. This will produce enough factor H to cover all three clinical phases.
Eleva Drug Candidate Examined for Use in COVID-19 Treatment americanpharmaceuticalreview
June 15, 2020
Eleva is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of the course of COVID-19.
Eleva's Drug Candidate Examined for Use in COVID-19 Treatment americanpharmaceuticalreview
June 10, 2020
Eleva is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of the course of COVID-19.